Coronaviruses Research in BRICS Countries

• Format: eBook
• Language: English
• Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• Subjects: Epidemiology and Medical statistics; Medicine and Nursing; aerosol; bioinformatics and vaccine development; Brazil; breakthrough; convalescent plasma; coronavirus disease 2019 (COVID-19); corticosteroids; COVID-19; COVID-19 and nanotechnology; COVID-19 testing; Delta and Delta plus variant; dental aerosol-generating procedures; detection; diabetes; different settings; E484K; epitope coverage; extra-oral suction; genomic epidemiology; high-volume evacuation; hospital mortality; humoral response; immunoassay; India; intervention strategies; intubation; low-volume saliva ejector; models; nanomedicine in South Africa; nanotechnology; neutralizing antibody (NAb); NSW; protein microarray; quantitative antibody binding; reverse zoonosis; SARS-CoV-2; SARS-CoV-2 antibodies; SARS-CoV-2 nucleocapsid protein; severe acute respiratory syndrome coronavirus (SARS-CoV-2); splatter; treatment; vaccine; vaccine development in South Africa; variant of Interest; VRDL; wildlife
• Online Access: Open Access: DOAB: description of the publication; Open Access: DOAB, download the publication
• Physical Description: 1 online resource (168 p.)
• ISBN: 9783036540276; 9783036540283; books978-3-0365-4027-6
• Access: Open Access

SARS-CoV-2 has infected more than 105 million people worldwide. During this pandemic, researchers and clinicians have been working to understand the molecular mechanisms that underpin viral pathogenesis by studying viral-host interactions. Now, with the global rollout of various COVID-19 vaccines-based on the neutralization of the spike protein using different technologies-viral immunology and cell-based immunity are being investigated. Researchers are also studying how various SARS-CoV-2 genetic mutations will impact the efficacy of these COVID-19 vaccines. At the same time, various antiviral drugs have been identified or repurposed that have potential as anti-SARS-CoV-2 treatments. BRICS (Brazil, Russia, India, China, and South Africa) is the acronym used to associate five major emerging national economies. The BRICS countries are known for their significant influence on regional affairs, including being leaders in scientific and clinical research and innovation. This Special Issue includes researchers from BRICS countries, in particular South Africa, involved in the study of SARS-CoV-2 and COVID-19. Original articles, as well as new perspectives or reviews on the matter, were welcomed. Research in the fields of vaccine studies, pathogenesis, genetic mutations, viral immunology, and antiviral drugs were especially encouraged.